Nu Skin Enterprises Inc (NUS.SG)
| Previous close | 11.00 |
| Open | 11.40 |
| Bid | 11.00 x 200000 |
| Ask | 11.10 x 200000 |
| Day's range | 11.00 - 11.40 |
| 52-week range | 11.00 - 35.60 |
| Volume | |
| Avg. volume | 1 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Nu Skin Enterprises to Announce First Quarter 2024 Financial Results
PROVO, Utah, April 03, 2024--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release first quarter 2024 results after the market closes on Wednesday, May 8. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will discuss recent results and upcoming business initiatives.
- PR Newswire
Nu Skin Launches RenuSpa iO, a New Personalized Beauty and Wellness Device
Nu Skin Enterprises (NYSE: NUS), a global beauty and wellness leader, today introduced Nu Skin RenuSpa iO, a smart beauty and wellness device designed to promote overall wellness and body confidence through skin stimulation. RenuSpa iO is an FDA-cleared microcurrent body device and the latest innovation from the world's best-selling brand for beauty device systems for six consecutive years.*
- Business Wire
Nu Skin Enterprises Reports Fourth Quarter and Full-year 2023 Results Above Company Guidance
PROVO, Utah, February 14, 2024--Nu Skin Enterprises Inc. (NYSE: NUS) today announced fourth quarter and full-year 2023 results slightly above its latest guidance.
